Charts

10 Feb, 2024
09 Feb, 2024

News

13 Feb, 2024
Gainers KalVista Pharma (NASDAQ:KALV) stock moved upwards by 31.5% to $21.1 during Tuesday's pre-market session. The market value of ...
01 Feb, 2024
On January 30, 2024, Steven Cohen (Trades, Portfolio)'s Point72 Asset Management made a significant move in the pharmaceutical sector by purchasing 850,001 shares of Iterum Therapeutics PLC (NASDAQ:ITRM), an Ireland-based clinical-stage pharmaceutical company. The transaction was executed at a trade price of $1.58 per share, marking a new holding for the firm in its diverse investment portfolio. This strategic buy reflects Cohen's confidence in Iterum Therapeutics, despite the company's current market capitalization of $21.095 million and a stock price closely trailing the trade price at $1.57.
30 Jan, 2024
Gainers SINTX Techs (NASDAQ:SINT) shares increased by 75.0% to $0.41 during Tuesday's after-market session. The market value of their ...
Iterum Therapeutics PLC (NASDAQ:ITRM) shares are trending Tuesday after the company announced its Phase 3 Reassure trial met the primary ...
Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next-generation oral antibiotics to treat infections caused by multi-drug resistant pathogens in community settings, today announced positive topline results from its REASSURE (REnewed ASsessment of Sulopenem in uUTI caused by Resistant Enterobacterales) Phase 3 clinical trial comparing oral sulopenem (sulopenem etzadroxil combined with probenecid in a bilayer tablet) to oral Augmentin®
28 Dec, 2023
The Dow Jones index closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence ...
04 Dec, 2023
DUBLIN, Ireland and CHICAGO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained com
28 Nov, 2023
Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 62.0% to $1.62 during Tuesday's regular session. The market value of ...
16 Nov, 2023
Gainers LumiraDx (NASDAQ:LMDX) shares rose 42.8% to $0.14 during Thursday's regular session. LumiraDx's stock is trading at a volume of ...
15 Nov, 2023
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Hello, everyone, and welcome to the Iterum Therapeutics Third Quarter 2023 Financial Results and Business Update. My name is Harry, and I’ll be your operator today. [Operator Instructions] And I will now hand the call over to Louise Barrett, Senior Vice President, […]
Q3 2023 Iterum Therapeutics PLC Earnings Call
14 Nov, 2023
Iterum Therapeutics (NASDAQ:ITRM) reported its Q3 earnings results on Tuesday, November 14, 2023 at 07:00 AM. Here's what investors need ...
-- Top-line Data for Pivotal REASSURE Trial Expected in Early Q1 2024 – --Resubmission of NDA for uUTI Expected in Q2 2024-- DUBLIN, Ireland and CHICAGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported financial results for the third quarter ende
13 Nov, 2023
Iterum Therapeutics (NASDAQ:ITRM) is set to give its latest quarterly earnings report on Tuesday, 2023-11-14. Here's what investors need ...
07 Nov, 2023
DUBLIN, Ireland and CHICAGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its third quarter 2023 financial results before the open of the U.S. financial markets on Tuesday, November 14, 2023. Management will
24 Oct, 2023
– Topline Data Expected in Early Q1 2024 – – NDA Resubmission Expected in Q2 2024 – DUBLIN, Ireland and CHICAGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced the completion of patient enrollment in its REASSURE (REnewed ASsessment of Sulopene
12 Oct, 2023
DUBLIN, Ireland and CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that three posters will be presented at the Infectious Disease Society of America’s IDWeek 2023 conference taking place in Boston, MA from October 11-15, 2023. Dat
12 Aug, 2023
Q2 2023 Iterum Therapeutics PLC Earnings Call
11 Aug, 2023
Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per ...
--Expect to Complete Enrollment in Q1 2024; Topline Data Expected in Q2 2024 ----Cash Runway into Q3 2024-- DUBLIN, Ireland and CHICAGO, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported financial results for the second quarter ended June 30, 2023.
10 Aug, 2023
Iterum Therapeutics (NASDAQ:ITRM) is set to give its latest quarterly earnings report on Friday, 2023-08-11. Here's what investors need ...
04 Aug, 2023
DUBLIN, Ireland and CHICAGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its second quarter 2023 financial results before the open of the U.S. financial markets on Friday, August 11, 2023. Management will h
27 Jun, 2023
Avalo (AVTX) announces that it failed to meet the primary endpoint in its mid-stage poorly controlled non-eosinophilic asthma study. The stock falls 89% on Monday following the news.
21 Jun, 2023
Catalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North America to Santhera's DMD treatment candidate, vamorolone, which is currently under FDA review.
12 Jun, 2023
DUBLIN, Ireland and CHICAGO, June 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that three posters will be presented at ASM Microbe 2023 conference. The hybrid conference will be held from June 15-19 at the George R. Brown Convention Center in
12 May, 2023
--Registration Trial for uUTI Ongoing and On Track-- --Cash Runway until Mid-2024-- DUBLIN, Ireland and CHICAGO, May 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today reported financial results for the first quarter ended March 31, 2023. “We remain on track to c
10 May, 2023
Nektar's (NKTR) Q1 loss is narrower than expected while revenues beat estimates.
20 Apr, 2023
DUBLIN, Ireland and CHICAGO, April 20, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that two posters were presented at the 33rd Annual European Congress of Clinical Microbiology and Infectious Disease (ECCMID) held in Copenhagen. The posters pres
13 Apr, 2023
Iterum Therapeutics PLC (ITRM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
31 Mar, 2023
Gainers G Medical Innovations (NASDAQ:GMVD) shares rose 45.2% to $2.41 during Friday's pre-market session. The market value of their ...
18 Mar, 2023
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Hello, everyone, and welcome to the Iterum Therapeutics Fourth Quarter and Full-Year 2022 Financial Results and Business Update. My name is Charlie, and I’ll be coordinating the call today. You will have the opportunity to ask questions at the end of the […]
15 Mar, 2023
06 Feb, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It
20 Jan, 2023
Gainers Iterum Therapeutics (NASDAQ:ITRM) shares moved upwards by 8.5% to $1.28 during Friday's after-market session. The company's ...
09 Jan, 2023
Gainers VYNE Therapeutics (NASDAQ:VYNE) shares rose 87.0% to $0.36 during Monday's after-market session. At the close, VYNE ...
15 Dec, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, ...
Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 112.9% to $0.5 during Thursday's pre-market session. The market value of their ...
24 Nov, 2022
Gainers Tenaya Therapeutics (NASDAQ:TNYA) shares increased by 16.4% to $2.84 during Thursday's after-market session. The company's ...
09 Nov, 2022
18 Aug, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 199.6% to close at $7.64 on Wednesday after the company announced ...
17 Aug, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
08 Aug, 2022
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are ...
13 Jul, 2022
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be ...
12 Jul, 2022
Gainers Canoo Inc. (NASDAQ: GOEV) shares jumped 79.9% to $4.2627 after Walmart signed a definitive agreement with the company to ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! Investors seeking news of the biggest pre-market stock movers for Tuesday are in the right place. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Gainers Versus Systems Inc. (NASDAQ: VS) rose 66% to $0.7802 in pre-market trading. Versus Systems, last month, received NASDAQ ...
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the ...
11 Jul, 2022
U.S. stocks traded lower toward the end of trading as investors digested the recent jobs report for the month of June. The Dow traded ...
Gainers Pliant Therapeutics (NASDAQ:PLRX) stock moved upwards by 104.5% to $18.16 during Monday's regular session. ...
Iterum Therapeutics plc(NASDAQ: ITRM) hasagreed with the FDAunder the special protocol assessment (SPA) process on ...
U.S. stocks traded lower midway through trading following the release of jobs report on Friday. The Dow traded down 0.50% to ...
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's a new week and that means it's time to check in on all of the short squeeze stocks that traders need to keep an eye on! The post 5 Top Short Squeeze Stocks to Watch This Week appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Iterum Therapeutics (ITRM) stock is taking off on Monday as investors react to news of a clinical trial agreement with the FDA. The post Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today? appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Gainers La Jolla Pharmaceutical (NASDAQ:LJPC) stock rose 80.8% to $6.13 during Monday's pre-market session. The ...
30 Jun, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company ...
29 Jun, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its ...
28 Mar, 2022
Iterum Therapeutics plc(NASDAQ: ITRM) has incurred aQ4 FY21 EPS loss of $(0.02)versus $(0.28) reported a year ago and ...
Iterum Therapeutics (NASDAQ:ITRM) reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM. Here's what ...
08:45
FinancialContent
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share ...
27 Mar, 2022
Biotech stocks reversed course in the week endingMarch 25, as an increase in risk appetite prompted traders to move money out of ...
25 Mar, 2022
15:08
FinancialContent
Iterum Therapeutics (NASDAQ:ITRM) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need ...
24 Mar, 2022
Iterum Therapeutics (NASDAQ:ITRM) will host a conference call at 08:30 AM ET on March 28, 2022, to discuss Q4 2021 earnings ...
12 Aug, 2021

Related Articles